Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Oriol De Fabregues"'
Autor:
Oriol De Fabregues, Jaume Viñas, Antoni Palasí, Manuel Quintana, Ignasi Cardona, Cristina Auger, Víctor Vargas
Publikováno v:
Brain and Behavior, Vol 10, Iss 5, Pp n/a-n/a (2020)
Abstract Objectives To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment of Wilson's disease (WD) with neurological symptoms. Methods An uncontrolled longitudinal study was carried out to describe a cas
Externí odkaz:
https://doaj.org/article/8a2053001c494337b5e9feffd4a9231b
Publikováno v:
Parkinson's Disease, Vol 2018 (2018)
Background. Sleep problems in patients with advanced Parkinson’s disease (PD) have a deleterious impact on quality of life. Objective. To assess the effect of levodopa-carbidopa intestinal gel (LCIG) infusion on sleep quality in advanced PD patient
Externí odkaz:
https://doaj.org/article/7fb093fd209941e3bfe0f60fadedd15a
Autor:
Víctor Gómez-Mayordomo, Isabel Gonzalez-Aramburu, Carmen Borrue fernandez, Mariateresa Buongiorno, Iria Cabo López, Andrea Horta-Barba, Astrid Daniela Adarmes Gómez, Juan Carlos Martinez Castrillo, Pedro Clavero-Ibarra, Berta María Pascual Sedano, JORGE HERNANDEZ-VARA, Lydia Lopez Manzanares, Diego Santos García, Monica Diez-Fairen, Jerónimo González-Bernal, Nuria López-Ariztegui, Jon Infante, María Ángeles Botí, Manuel Menéndez González, Carlos Manuel Ordás Bandera, Monica Kurtis, Oriol De Fabregues, Ignacio Alvarez, M Isabel Morales-Casado, Pedro Gámez-Beltrán, Lydia Vela-Desojo
Publikováno v:
Journal of Parkinson's Disease. 10:1611-1620
Background: The asymmetry of motor manifestations present in Parkinson’s disease (PD) suggests the existence of differences between both hemispheres. As a consequence, this asymmetry might contribute to different PD clinical phenotypes. Objective:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccc58112c30c990aa1dd5209df89f7fa
https://doi.org/10.3233/jpd-202067
https://doi.org/10.3233/jpd-202067
Autor:
Ane Crespo-Cuevas, Antonia Campolongo, Cristina Izquierdo-Barrionuevo, Javier Pagonabarraga, Helena Bejr-Kasem, Berta Pascual-Sedano, Saul Martinez-Horta, Juan Marín-Lahoz, Jaime Kulisevsky, Matilde Calopa, Andrea Horta-Barba, Víctor Puente, Oriol De Fabregues, Ignacio Aracil-Bolaños, Jesús Pérez-Pérez
Publikováno v:
Journal of neurology. 267(11)
Chronic levodopa treatment in Parkinson’s disease (PD) may promote undesirable motor and non-motor fluctuations. Compared to chronic oral levodopa treatment, continuous infusion of levodopa/carbidopa intestinal gel (LCIG) in advanced PD reduces mot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6498879a806ff13dd7fd501cac1f416b
https://pubmed.ncbi.nlm.nih.gov/32607644
https://pubmed.ncbi.nlm.nih.gov/32607644
Autor:
Joaquín A. Fernández-Ramos, Belén Pérez-Dueñas, Laura Martí-Sánchez, Jesús Eiris, Maite Gárriz-Luis, Marta Correa-Vela, Anna Cazurro, Laura Toledo, J. Cabrera, Elena Maqueda, Gema Iglesias, Sergio Aguilera-Albesa, Alfons Macaya, Marcos Madruga, Carla Rodríguez, Anna Marcé-Grau, Carmen Espinós, Heidy Baide-Mairena, Oriol De Fabregues, Maria Isabel Vanegas, María José Martí, Roser Pons, Sara Mellid
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
PARKINSONISM & RELATED DISORDERS
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
PARKINSONISM & RELATED DISORDERS
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Objective To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Method Two movement disorders experts rated patients with the Burke-Fahn-Marsden and Unified-Myoclonus rating scales us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64d2943ab9cacbce94691633e2b394c
https://pubmed.ncbi.nlm.nih.gov/33022436
https://pubmed.ncbi.nlm.nih.gov/33022436
Autor:
Matilde Calopa, Lluís Planellas, Ana Cámara, Esteban Muñoz, Darly M. Giraldo, Serge Jauma Classen, Asunción Ávila, Jorge Hernández-Vara, Rubén Fernández-Santiago, Francesc Valldeoriola, Paloma Bravo, Montserrat Pujol, Carles Gaig, J. Pagonabarraga, Mario Ezquerra, Teresa Botta, Neus Fabregat, Sara P. Dias, Miquel Aguilar, José Ríos, Manel Fernández, Marta Pulido-Salgado, Eduardo Tolosa, Àngels Bayés, Oriol De Fabregues, Gian Gaetano Tartaglia, Pau Pastor, Claustre Pont, Víctor Puente, Yaroslau Compta, Almudena Sánchez, Josep Saura, Jaume Campdelacreu, Celia Painous, Nuria Caballol, María José Martí, Alexandra Pérez-Soriano
Publikováno v:
PARKINSONISM & RELATED DISORDERS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Parkinsonism and Related Disorders, 65, 3-12. Elsevier BV
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Parkinsonism and Related Disorders, 65, 3-12. Elsevier BV
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Introduction: Neuroinflammation is a potential player in neurodegenerative conditions, particularly the aggressive ones, such as multiple system atrophy (MSA). Previous reports on cytokine levels in MSA using serum or cerebrospinal fluid (CSF) have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a039806fa994ea0c4b21562abcd220
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2518
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2518
Autor:
Francesc Valldeoriola, Lluís Planellas, Francesca Antonelli, Darly M. Giraldo, Serge Jaumà, Manel Fernández, Paloma Bravo, Claustre Pont-Sunyer, Mario Ezquerra, Josep Saura, Rubén Fernández-Santiago, Eduard Tolosa, Jaume Campdelacreu, Domenica Marchese, Nuria Caballol, Esteban Muñoz, María José Martí, Oriol De Fabregues, Pau Pastor, Montserrat Pujol, Matilde Calopa, Yaroslau Compta, Marta Soto, Ana Cámara, Víctor Puente, Gian Gaetano Tartaglia, Jorge Hernández-Vara, Teresa Botta-Orfila, Javier Pagonabarraga, Àngels Bayés, Ferran Torres, Asunción Ávila
Introduction The finding of mutations of the COQ2 gene and reduced coenzyme Q10 levels in the cerebellum in multiple system atrophy (MSA) suggest that coenzyme Q10 is relevant to MSA pathophysiology. Two recent studies have reported reduced coenzyme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85deda96c149e988ee008cf3bdc4a805
http://hdl.handle.net/11573/1451347
http://hdl.handle.net/11573/1451347
Autor:
Miquel Aguilar, Francisco Lomeña, Pilar Casquero, María José Martí, Dolores Vilas, Eduardo Tolosa, Ramiro Álvarez, Francesc Valldeoriola, Jorge Hernández-Vara, José Ríos, Víctor Puente, Claustre Pont-Sunyer, Oriol De Fabregues, Lourdes Ispierto, Yaroslau Compta, Serge Jaumà, Pilar Quílez, Jaume Campdelacreu, Matilde Calopa
Publikováno v:
Parkinsonism & Related Disorders. 21:1170-1176
Substantia nigra hyperechogenicity (SN+) has been proposed as a risk marker of Parkinson's disease (PD). Asymptomatic LRRK2 mutation carriers (aLRRK2+), at high risk for developing PD, provide an opportunity for the study of preclinical biomarkers.To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246f3f70a454f39985e1c986ad96e76b
https://doi.org/10.1016/j.parkreldis.2015.08.007
https://doi.org/10.1016/j.parkreldis.2015.08.007
Autor:
Berta Pascual-Sedano, Antonia Campolongo, Oriol de Fabregues-Nebot, Francesca Antonelli, Matilde Calopa, Mariateresa Buongiorno, Eduardo Tolosa, Ana Cámara, Jaime Kulisevsky, Francesc Valldeoriola, Jorge Hernández-Vara, María José Martí, Víctor Puente
Publikováno v:
Parkinsonism & Related Disorders. 21:871-876
Introduction Continuous infusion of levodopa/carbidopa intestinal gel (LCIG) is an effective treatment for patients with advanced Parkinson Disease (PD) that cannot be further improved by oral therapy. Methods We conducted an observational, prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3062ec20ddde7722279e74590cbdf2
https://doi.org/10.1016/j.parkreldis.2015.05.014
https://doi.org/10.1016/j.parkreldis.2015.05.014